Attached files

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported) August 5, 2011


                       BUSINESS OUTSOURCING SERVICE, INC.
             (Exact name of registrant as specified in its charter)

                                     Nevada
                 (State or other jurisdiction of incorporation)

                                    000-54329
                            (Commission File Number)

                                   98-0583166
                        (IRS Employer Identification No.)

             1001 SW 5th Avenue, Suite 1100, Portland, Oregon, 97204
              (Address of principal executive offices and Zip Code)

                                 (503) 206-0935
              (Registrant's telephone number, including area code)

                                       N/A
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On August 5, 2011 we  announced  we signed a letter of intent  with Prof.  Sarah
Ferber and Ms.  Vered  Caplan to have them use their best efforts to negotiate a
license  agreement  on behalf of our company  with the Sheba  Medical  Center to
acquire the exclusive rights to their functional  autologous  insulin  producing
cells (AIPC) regeneration technology.

A copy of our letter of intent and press release are attached as exhibits to our
current report and are incorporated by reference.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

10.1 Letter of Intent dated August 4, 2011 with Prof. Sarah Ferber and Ms. Vered
     Caplan

99.1 news release dated August 5, 2011

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

BUSINESS OUTSOURCING SERVICE, INC.


/s/ Guilbert Cuison
----------------------------------
Guilbert Cuison
President, Secretary Director
August 8, 2011